Examples of Our Work in Cardiovascular
Value of Model-Based Approaches That Integrate Animal Biomarker Data and Public Literature on Competitors to Project Safety/Efficacy and Phase I Dose for a Direct Factor Xa Inhibitor.
Competitive Positioning Case Study: Do We Really Need Another Anti-Platelet? 
®
PK/PD-based Modeling and Simulation Strategy and Use of DMX® Visualization Technology to Support Decision-Making in Early Development for a Novel Cholesterol-Lowering Agent
Strategies to Improve Model-Based Decision-Making During Clinical Development
Population Pharmacokinetic Case Study in Hypertension